Clinical Trials

Breast Neoplasms

NCT03804255 2026-04-03

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06229392 2026-03-11

A Study to Evaluate the Intratumoral Influenza Vaccine Administration in Patients With Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms, Influenza, Human, Triple Negative Breast Neoplasms

NCT07439432 2026-02-27

Stereotactic Guided Biopsy and Cryoablation

Breast Neoplasms

NCT05014295 2026-02-24

Patient Recall of Cancer Screening and Diagnosis

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT06829199 2026-02-19

MK-5890-003

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06585969 2026-02-12

DISCORDANT

Phase 3 Withdrawn

Breast Neoplasms

NCT05512260 2026-02-11

BESTa

BreastGastrointestinalGynecologic

Breast Neoplasms, Ovarian Neoplasms, Colorectal Neoplasms

NCT06613516 2025-12-24

CaptAin

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT05957042 2025-12-10

Pilot Study to Evaluate if Contrast Enhanced Ultrasound (CEUS) Can Predict Treatment Response in Triple Negative Breast Cancer (TNBC) Patients Receiving Combined Chemotherapy and Immune Checkpoint Inhibitors (ICI).

Breast Neoplasms

NCT04188119 2025-12-08

IMpALA

Breast Neoplasms

NCT07092475 2025-11-26

The Impact of Intraoperative Methadone on Postoperative Opioid Use

Phase 3 Withdrawn

Breast Neoplasms

NCT02825810 2025-11-18

Cervical Motor Control in Long-term Breast Cancer Survivors

Breast Neoplasms, Neck Pain

NCT05634954 2025-10-23

Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms

NCT04794816 2025-10-14

What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care

Breast Neoplasms

NCT06884254 2025-10-14

EGC102

Phase 3 Withdrawn

Breast Neoplasms

NCT03974204 2025-09-26

Analyses of Exosomes in the Cerebrospinal Fluid for Breast Cancer Patients With Suspicion of Leptomeningeal Metastasis.

BreastCNS

Breast Neoplasms, Meningeal Carcinomatosis

NCT06597773 2025-09-26

Online Patient Navigation Program for Patients With Breast Cancer

Breast Neoplasms

NCT06672224 2025-09-17

Indocyanine Green Fluoroscopy and SPY Angiography for the Assessment of Lymphatic Structure in Breast Cancer Patients at Risk for Breast Cancer-Related Lymphedema

Breast Cancer Lymphedema, Breast Neoplasms

NCT01827969 2025-09-16

USF

Breast Neoplasms

NCT00466830 2025-09-11

SDPM

Breast Neoplasms, Pain

NCT00210145 2025-09-04

ASE K SEIN

Breast Neoplasms

NCT04756765 2025-08-17

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

Breast Neoplasms

NCT05678205 2025-07-30

A Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid Tumors

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms

NCT06852560 2025-06-26

GEM

Breast Neoplasms, Atherosclerosis

NCT03941223 2025-06-25

Regional Anesthesia for Breast Surgery

Breast Neoplasms

NCT06494046 2025-06-04

Defining Musical Toxicity and Its Effect on Patient Well-being

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT05990478 2025-05-21

A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer

Phase EARLY_PHASE1 Withdrawn

Breast Neoplasms

NCT06145399 2025-05-18

A Study of 1 8F-FDHT PET/MRIScans in Women With Breast Cancer

Breast Neoplasms

NCT06978478 2025-05-18

IMETAB6

Breast Neoplasms

NCT01349088 2025-05-02

Investigational Drug in Combination With Two Chemotherapy Drugs in Women With Locally Recurrent or Metastatic Breast Cancer

Breast Neoplasms

NCT04418219 2025-04-29

Breast Cancer Vaccine in Combination With Pembrolizumab for Treatment of Persistent, Recurrent, or Metastatic Breast Cancer

Breast Neoplasms

NCT06938711 2025-04-22

A Rollover Protocol of Elacestrant, in Combination With Onapristone, for Patients With ER+, PR+, HER2- Advanced or Metastatic Breast Cancer